The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Malignancy in giant cell tumor of bone
Open accessAbstract
BACKGROUND: The term malignant giant cell tumor embraces multiple entities and therefore can be confusing. The goals of the current study were to define the clinicopathologic and histologic features of malignancy in giant cell tumors and to clarify the terminology. METHODS: The authors reviewed all cases from the Rizzoli Institute (Bologna, Italy) of primary (PMGCT) and secondary (SMGCT) malignancy in giant cell tumors. PMGCT is a high‐grade sarcoma that arises side by side with benign giant cell tumors. SMGCT is a high‐grade sarcoma that occurs at the sites of previously treated giant cell tumors of bone. RESULTS: The authors report 5 PMGCTs and 12 SMGCTs; half of the SMGCTs were postradiation sarcomas. Patient age ranged from 20 to 68 years (median, 62 years) for PMGCT and from 30 to 77 years (median, 40 years) for SMGCT. The average latent period between diagnosis of giant cell tumor and diagnosis of SMGCT was 9 years (range, 3–15 years) for patients with postradiation SMGCT and 19 years (range, 7–28 years) for patients with SMGCT resulting from spontaneous transformation. The histologic classification of high‐grade sarcomas in the PMGCT group was osteosarcoma in four cases and malignant fibrous histiocytoma in one case. In the SMGCT group, the histologic classification was osteosarcoma in nine cases, fibrosarcoma in two cases, and malignant fibrous histiocytoma in one case. The outcomes associated with all malignancies in giant cell tumors were poor, with the worst outcome associated with postradiation SMGCT. CONCLUSIONS: Malignancies in giant cell tumors of bone always are high‐grade sarcomas with a poor prognosis. These lesions must be distinguished from benign giant cell tumors of bone. SMGCT usually is easy to diagnose upon malignant clinicoradiographic presentation. In contrast, PMGCT often mimics giant cell tumors both clinically and radiographically. In addition, upon histologic examination, PMGCT shows areas of conventional giant cell tumor, which can lead to difficulties in making the correct diagnosis. Cancer 2003;97:2520–9. © 2003 American Cancer Society. DOI 10.1002/cncr.11359
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Campanacci, M., Baldini, N., Boriani, S., & Sudanese, A. (1987) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198769010-00018 · Cited by 1,481
Sarcoma in irradiated bone. Report of eleven cases
Cahan, W. G., Woodard, H. Q., Higinbotham, N. L., Stewart, F. W., & Coley, B. L. (1948) · Cancer · doi:10.1002/1097-0142(194805)1:1<3::aid-cncr2820010103>3.0.co;2-7 · Cited by 1,095
Giant-cell tumor: A study of 195 cases
Dahlin, D. C., Cupps, R. E., & Johnson, E. W. (1970) · Cancer · doi:10.1002/1097-0142(197005)25:5<1061::aid-cncr2820250509>3.0.co;2-e · Cited by 606
Bone Tumors: Clinical, Radiologic, and Pathologic Correlations
Mirra, J. M., Picci, P., & Gold, R. H. (1989) · Medical Entomology and Zoology · Cited by 490
Radiation-induced sarcoma of bone
Arlen, M., Higinbotham, N. L., Huvos, A. G., Marcove, R. C., Miller, T., & Shah, I. C. (1971) · Cancer · doi:10.1002/1097-0142(1971)28:5<1087::aid-cncr2820280502>3.0.co;2-f · Cited by 483
Dahlin's Bone Tumors. General Aspects and Data on 11,087 Cases
Devaney, K. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00019 · Cited by 439
Bone Tumors. Clinical, Radiologic, and Pathologic Correlations.
Bonfiglio, M. (1990) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199072040-00032 · Cited by 427
Hutter, R. V. P., Worcester, J. N., Francis, K. C., Foote, F. W., & Stewart, F. W. (1962) · Cancer · Cited by 231
Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients.
Rock, M. G., Sim, F. H., Unni, K. K., Witrak, G. A., Frassica, F. J., Schray, M. F., Beabout, J. W., & Dahlin, D. C. (1986) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198668070-00016 · Cited by 184
Treatment of giant-cell tumor of the pelvis.
Sanjay, B. K. S., Frassica, F. J., Frassica, D. A., Unni, K. K., McLeod, R. A., & Sim, F. H. (1993) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199310000-00007 · Cited by 102
Cited by
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
Thomas, D., Henshaw, R., Skubitz, K., Chawla, S., Staddon, A., Blay, J.-Y., Roudier, M., Smith, J., Ye, Z., Sohn, W., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70010-3 · Cited by 716
The 2020 WHO Classification of Tumors of Bone: An Updated Review
Choi, J. H., & Ro, J. Y. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000293 · Cited by 395
Late sarcoma development after curettage and bone grafting of benign bone tumors
Picci, P., Sieberova, G., Alberghini, M., Balladelli, A., Vanel, D., Hogendoorn, P. C. W., & Mercuri, M. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.06.053 · Cited by 28
What’s new in musculoskeletal oncology
Errani, C., Mavrogenis, A. F., & Tsukamoto, S. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04590-1 · Cited by 11
Metadata
- Authors
- Bertoni, F., Bacchini, P., & Staals, E. L.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-04-30
- Volume
- 97
- Issue
- 10
- Pages
- 2520-2529
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2090082358
- Cited by
- 257
- References
- 19
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malignancy in giant cell tumor of bone. https://app.cochat.ai/papers/10.1002/cncr.11359
- The paper
- Bertoni, F., Bacchini, P., & Staals, E. L. (2003). Malignancy in giant cell tumor of bone. Cancer. https://doi.org/10.1002/cncr.11359
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.